Literature DB >> 21153661

Outcome of surgical treatment for patients with locoregional recurrence of gastric cancer.

Souya Nunobe1, Naoki Hiki, Shigekazu Ohyama, Susumu Aikou, Takeshi Sano, Toshiharu Yamaguchi.   

Abstract

PURPOSE: Locoregional recurrent gastric cancer is commonly treated by systemic chemotherapy. The effectiveness of surgical treatment, in terms of complete tumor resection, is unknown.
METHODS: We reviewed the case histories of 36 patients with locoregional recurrent gastric cancer, selected for surgical treatment by careful preoperative assessment. Patient characteristics and survival data were collected and analyzed. Prognostic factors were also assessed by univariate analysis using the log-rank test.
RESULTS: Among 36 patients with recurrent gastric tumors, including 18 patients with local recurrences and 18 patients with single-regional lymph node recurrences, the average time to recurrence after initial surgery was 26.4 ± 2.8 months. Complete resection was possible in 29 patients (80.6%), with incomplete resection in the remaining seven patients (19.4%). Various types of surgery were used for tumor recurrence; 23 patients (63.9%) underwent procedures to resect the tumor and the affected organs. The median survival time (median ± standard error) was 23.0 ± 2.8 months, and overall 1-, 3-, and 5-year survival rates were 73.0%, 36.7%, and 9.8%, respectively. Complete resectability of the tumor was the only significant prognostic factor identified.
CONCLUSIONS: Although there was no control group in the present study with similarly limited tumor recurrence and treated solely with modern systemic chemotherapy, such a study population would be too small to conduct a randomized study in. For those patients for whom surgery is indicated by multidisciplinary assessment, surgical resection can be applied for recurrent lesions if complete resection can be accomplished with low perioperative risk for the extended surgery.

Entities:  

Mesh:

Year:  2010        PMID: 21153661     DOI: 10.1007/s00423-010-0730-2

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  20 in total

1.  Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile?

Authors:  H Böhner; T Zimmer; W Hopfenmüller; G Berger; H J Buhr
Journal:  Hepatogastroenterology       Date:  2000 Sep-Oct

2.  The role of surgery in the treatment of recurrent gastric cancer.

Authors:  Kyo-Young Song; Seung-Man Park; Seung-Nam Kim; Cho-Hyun Park
Journal:  Am J Surg       Date:  2008-04-16       Impact factor: 2.565

3.  The resection of non-hepatic intraabdominal recurrence of gastric cancer.

Authors:  I Takeyoshi; S Ohwada; T Ogawa; Y Kawashima; T Ohya; S Kawate; Y Nakasone; K Arai; T Ikeya; Y Morishita
Journal:  Hepatogastroenterology       Date:  2000 Sep-Oct

4.  [Reoperation of recurrent gastric cancer--a comparative study of a resected and nonresected group].

Authors:  M Sunagawa; K Takeshita; A Nakajima; K Ochi; H Habu; K Hoshi
Journal:  Gan No Rinsho       Date:  1984-12

5.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

6.  Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up.

Authors:  J Estape; J J Grau; F Lcobendas; J Curto; M Daniels; N Viñolas; C Pera
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

7.  Is the follow-up of patients operated on for gastric carcinoma of benefit to the patient?

Authors:  M Huguier; S Houry; F Lacaine
Journal:  Hepatogastroenterology       Date:  1992-02

8.  Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.

Authors:  T Yoshikawa; M Sasako; S Yamamoto; T Sano; H Imamura; K Fujitani; H Oshita; S Ito; Y Kawashima; N Fukushima
Journal:  Br J Surg       Date:  2009-09       Impact factor: 6.939

9.  Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma.

Authors:  C G Moertel; D S Childs; J R O'Fallon; M A Holbrook; A J Schutt; R J Reitemeier
Journal:  J Clin Oncol       Date:  1984-11       Impact factor: 44.544

10.  Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.

Authors:  S Pyrhönen; T Kuitunen; P Nyandoto; M Kouri
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more
  8 in total

1.  Chemoradiotherapy for patients with recurrent lymph-node metastasis or local recurrence of gastric cancer after curative gastrectomy.

Authors:  Kenji Ishido; Katsuhiko Higuchi; Satoshi Tanabe; Mizutomo Azuma; Tohru Sasaki; Chikatoshi Katada; Shouko Komori; Kazushige Hayakawa; Kei Hosoda; Keishi Yamashita; Natsuya Katada; Wasaburo Koizumi
Journal:  Jpn J Radiol       Date:  2015-11-17       Impact factor: 2.374

2.  Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer.

Authors:  Liangrong Shi; Changping Wu; Jun Wu; Wenjie Zhou; Mei Ji; Hongyu Zhang; Jiemin Zhao; Yuanquan Huang; Honglei Pei; Zhong Li; Jingfang Ju; Jingting Jiang
Journal:  Radiat Oncol       Date:  2012-07-24       Impact factor: 3.481

3.  Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed.

Authors:  Masanori Watanabe; Hideyuki Suzuki; Kentaro Maejima; Osamu Komine; Satoshi Mizutani; Masanori Yoshino; Hideki Bo; Yasuhiko Kitayama; Eiji Uchida
Journal:  Med Sci Monit       Date:  2012-07

4.  Cumulative radiation exposure during follow-up after curative surgery for gastric cancer.

Authors:  Yeo Jin Lee; Yong Eun Chung; Joon Seok Lim; Joo Hee Kim; Young Jin Kim; Hye-Jeong Lee; Je Sung You; Myeong-Jin Kim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2012-03-07       Impact factor: 3.500

5.  Surgical resection of colorectal recurrence of gastric cancer more than 5 years after primary resection.

Authors:  Takehiro Noji; Yoshiyuki Yamamura; Jun Muto; Aki Kuroda; Junkichi Koinuma; Tatsuya Yoshioka; Katsuhiko Murakawa; Setsuyuki Otake; Satoshi Hirano; Koichi Ono
Journal:  Int J Surg Case Rep       Date:  2014-10-19

6.  Early gastric cancer metastasizing to the rectum, possibly via a hematogenous route: a case report and review of literature.

Authors:  Norio Uemura; Junji Kurashige; Keisuke Kosumi; Masaaki Iwatsuki; Kohei Yamashita; Shiro Iwagami; Yoshifumi Baba; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Yumi Honda; Yoshiki Mikami; Hideo Baba
Journal:  Surg Case Rep       Date:  2016-06-07

Review 7.  Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review.

Authors:  Haruo Matsushita; Keiichi Jingu; Rei Umezawa; Takaya Yamamoto; Yojiro Ishikawa; Noriyoshi Takahashi; Yu Katagiri; Noriyuki Kadoya
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

8.  SALVAGE SURGERY IN GASTRIC CANCER.

Authors:  Italo Beltrão Pereira Simões; Marina Alessandra Pereira; Marcus Fernando Kodama Pertille Ramos; Ulysses Ribeiro Junior; Bruno Zilberstein; Sergio Carlos Nahas; Andre Roncon Dias
Journal:  Arq Bras Cir Dig       Date:  2022-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.